P2.09. Aumolertinib Combined with Carbamazepine and Intrathecal Pemetrexed for EGFR-mutated LM NSCLC with Symptomatic Epilepsy - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Li Li
Meta Tag
Speaker Li Li
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
clinical trial
EGFR-mutated leptomeningeal metastasis
non-small cell lung cancer
combination therapy
intrathecal pemetrexed
symptomatic epilepsy
overall survival
anti-epileptic treatment
Powered By